Filana Therapeutics Reports Simufilam Findings Published in Cells
The company announced publication of preclinical findings for simufilam in TSC2-deficient cells.
Related stories
APAR Industries Q2 2027 Earnings Call Begins
APAR Industries’ quarterly earnings call has begun.
M impact | EQUITY | Oct 29, 2026, 09:57 AM UTC
Takeda Pharmaceutical Company’s Q2 2027 earnings call begins
Takeda Pharmaceutical Company’s quarterly earnings call has begun.
M impact | EQUITY | Oct 29, 2026, 09:57 AM UTC
Montage Tech Q3 Net Profit Rises 161.98% Year Over Year
M impact | EQUITY | Oct 29, 2026, 09:56 AM UTC
Axis Real Estate Investment Trust Reports Q3 2026 Revenue of 90.8 Million RGT
M impact | EQUITY | Oct 29, 2026, 09:56 AM UTC
Axis Real Estate Investment Trust Reports Q3 2026 Profit of 54.8 Million RGT
M impact | EQUITY | Oct 29, 2026, 09:56 AM UTC
Haitian Flavoring's Q3 net profit falls more than a tenth
Haitian Flavoring reported third-quarter revenue of 64.1 hundred-million yuan, nearly flat year over year. The headline says net profit fell by more than a tenth.
M impact | EQUITY | Oct 29, 2026, 09:56 AM UTC